...
首页> 外文期刊>Bone marrow transplantation >Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation
【24h】

Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation

机译:ABO错配对脐血移植后GVHD风险的影响

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Recent advances in allogeneic hematopoietic cell transplant (allo-HCT) have led to an increasing use of alternative donors, including banked umbilical cord blood (UCB). Despite these advances, acute GVHD (aGVHD) and chronic GVHD (cGVHD) continue to be the leading causes of early and late transplant-related mortality. ABO-mismatch has been frequently reported as a risk factor for GVHD, however, data in the UCB recipients are limited. We hypothesized that as the lymphocytes in the cord blood are thought to be naive, they will therefore be less likely to mediate GVHD. Therefore, we analyzed the impact of ABO-mismatch on aGVHD and cGVHD in recipients of single and double UCB-HCT. In both univariate and multivariate analyses, presence of ABO-mismatch did not have an impact on aGVHD or cGVHD. Whereas ABO-compatible donors are preferred in recipients of URD-HCT, ABO compatibility generally need not be considered in recipients of UCB-HCT.
机译:同种异体造血细胞移植(allo-HCT)的最新进展已导致替代供体的使用增加,包括脐带血(UCB)。尽管取得了这些进展,但是急性GVHD(aGVHD)和慢性GVHD(cGVHD)仍然是早期和晚期移植相关死亡率的主要原因。 ABO不匹配经常被报告为GVHD的危险因素,但是UCB接收者中的数据有限。我们假设由于脐带血中的淋巴细胞被认为是幼稚的,因此它们介导GVHD的可能性较小。因此,我们分析了单双UCB-HCT接受者中ABO不匹配对aGVHD和cGVHD的影响。在单变量和多变量分析中,ABO不匹配的存在都不会对aGVHD或cGVHD产生影响。尽管UBO-HCT的接受者首选ABO相容的供体,但UCB-HCT的接受者通常不需要考虑ABO的相容性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号